Literature DB >> 16112207

The use of viral vectors to produce hepatitis B virus core particles in plants.

I A Mechtcheriakova1, M A Eldarov, L Nicholson, M Shanks, K G Skryabin, G P Lomonossoff.   

Abstract

The expression and assembly of the hepatitis B virus (HBV) nucleocapsid protein (HBcAg) were investigated in plants using viral vectors. Constructs based on either Potato virus X (PVX) or Cowpea mosaic virus (CPMV) containing the sequence of HBcAg were able to infect the appropriate host plants and remained genetically stable during infection. Analysis of HBcAg expression revealed that the protein can self-assemble into core-like particles and that the assembled material could be partially purified by differential centrifugation. Thus, the use of viral vectors can be considered a practical method for rapid production of assembled HBcAg particles in plants. This approach provides a means whereby a variety of chimaeric particles can be assessed quickly and cheaply for various diagnostic and vaccine applications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112207     DOI: 10.1016/j.jviromet.2005.06.020

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  24 in total

Review 1.  Virus-like particles production in green plants.

Authors:  Luca Santi; Zhong Huang; Hugh Mason
Journal:  Methods       Date:  2006-09       Impact factor: 3.608

2.  Extremely high-level and rapid transient protein production in plants without the use of viral replication.

Authors:  Frank Sainsbury; George P Lomonossoff
Journal:  Plant Physiol       Date:  2008-09-05       Impact factor: 8.340

3.  Transient expression of anti-VEFGR2 nanobody in Nicotiana tabacum and N. benthamiana.

Authors:  Mostafa Modarresi; Mokhtar Jalali Javaran; Masoud Shams-Bakhsh; Sirous Zeinali; Mahdi Behdani; Malihe Mirzaee
Journal:  3 Biotech       Date:  2018-11-15       Impact factor: 2.406

4.  A DNA replicon system for rapid high-level production of virus-like particles in plants.

Authors:  Zhong Huang; Qiang Chen; Brooke Hjelm; Charles Arntzen; Hugh Mason
Journal:  Biotechnol Bioeng       Date:  2009-07-01       Impact factor: 4.530

5.  Plant-based production can result in covalent cross-linking of proteins.

Authors:  Roger Castells-Graells; George P Lomonossoff
Journal:  Plant Biotechnol J       Date:  2021-05-04       Impact factor: 9.803

6.  RNA viral vectors for improved Agrobacterium-mediated transient expression of heterologous proteins in Nicotiana benthamiana cell suspensions and hairy roots.

Authors:  Jeffrey S Larsen; Wayne R Curtis
Journal:  BMC Biotechnol       Date:  2012-05-06       Impact factor: 2.563

7.  Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins.

Authors:  Hadrien Peyret; Annick Gehin; Eva C Thuenemann; Donatienne Blond; Aadil El Turabi; Lucy Beales; Dean Clarke; Robert J C Gilbert; Elizabeth E Fry; David I Stuart; Kris Holmes; Nicola J Stonehouse; Mike Whelan; William Rosenberg; George P Lomonossoff; David J Rowlands
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

Review 8.  The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects?

Authors:  Tomasz Pniewski
Journal:  Int J Mol Sci       Date:  2013-01-21       Impact factor: 5.923

9.  A VLP library of C-terminally truncated Hepatitis B core proteins: correlation of RNA encapsidation with a Th1/Th2 switch in the immune responses of mice.

Authors:  Irina Sominskaya; Dace Skrastina; Ivars Petrovskis; Andris Dishlers; Ieva Berza; Maria Mihailova; Juris Jansons; Inara Akopjana; Irina Stahovska; Dzidra Dreilina; Velta Ose; Paul Pumpens
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

Review 10.  N-glycosylation modification of plant-derived virus-like particles: an application in vaccines.

Authors:  Hyun-Soon Kim; Jae-Heung Jeon; Kyung Jin Lee; Kisung Ko
Journal:  Biomed Res Int       Date:  2014-05-25       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.